Natural history and treatment sensitivity of alveolar soft part sarcoma: A national multicenter analysis from the French sarcoma group

Sarcoma

Maintenance Chemotherapy in Patients With High-Risk Rhabdomyosarcoma: Long-Term Survival Analysis of the European Paediatric Soft Tissue Sarcoma Study Group RMS 2005 Trial

J Clin Oncol

Bisogno G, Chisholm J, Hladun R, De Salvo GL, Guerin F, Casanova M, Mandeville H, Alaggio R, Coppadoro B, Orbach D, Ferrari A, van Rijn R, Defachelles AS, Ben-Arush M, Glosli H, Cesen M, Merks JHM, Minard-Colin V

doi: 10.1200/JCO-24-02850

Sarcoma

Outcome of 1773 superficial non-dermatofibrosarcoma sarcomas A French Sarcoma Group study (FSG) from the NETSARC database

Eur J Cancer

Bompas E, Campion L, Toulmonde M, Le Cesne A, Saint-Jean M, Lebbe C, Valentin T, Rios M, Duffaud F, Firmin N, Carrère S, Piperno-Neumann S, Perrin C, Ropars M, Bonvalot S, Watson S, Tzanis D, Boudou-Roquette P, Tlemsani C, de Percin S, Desmoulin I, Causeret S, Ducoulombier A, Saada-Bouzid E, Bertucci F, Kurtz JE, Gantzer J, Brahmi M, Dufresne A, Gouin F, Meeus P, Italiano A, Michot A, Spatalo-Ceruso M, Verret B, Honoré C, Ryckewaert T, Decanter G, Mattei JC, Gangloff D, Salas S, Narciso B, Moreau-Bachelard C, Le Nail LR, Dubray-Longeras P, Fiorenza F, Chagneau L, Guillemet C, Penel N, Blay JY

doi: 10.1016/j.ejca.2025.115788

Gastrointestinal Cancer

First-line treatment efficacy of anti-EGFR versus anti-VEGF antibodies in BRAF(V600E)-mutated metastatic colorectal cancer according to primary tumor sidedness: A pooled analysis of seven clinical trials performed in the first-line treatment of mCRC (German AIO Study Group)

Eur J Cancer

Weiss L, Stintzing S, Modest DP, Stahler A, von Weikersthal LF, Reinacher-Schick A, Decker T, Probst V, Heinrich K, Schwaner I, Kaiser F, Pihusch R, Fuchs M, Held S, Alig A, Gruenberger B, Prager GW, Tougeron D, Taieb J, Heinemann V

doi: 10.1016/j.ejca.2025.116105

Genitourinary Cancer

Efficacy and safety of treatments for metastatic castration-sensitive prostate cancer: A comprehensive network meta-analysis including final ARANOTE data

Prostate Cancer Prostatic Dis

Shore N, Morgans AK, Paracha N, Gallagher E, Thom H, Aceituno D, Orishaba P, Stefani S, Trinh QD, Wallis CJD, Abrams KR, Boegemann M

doi: 10.1038/s41391-025-01054-8

Leukemia

Multi-dimensional analysis of adult acute myeloid leukemia cross-continents reveals age-associated trends in mutational landscape and treatment outcomes (Acute Myeloid Leukemia Cooperative Group & Alliance for Clinical Trials in Oncology)

Leukemia

Cusan M, Larkin K, Nicolet D, Jurinovic V, Mrózek K, Batcha AMN, Rothenberg-Thurley M, Schneider S, Sauerland C, Görlich D, Krug U, Berdel WE, Woermann BJ, Hiddemann W, Braess J, Spiekermann K, Greif PA, Blachly JS, Mims AS, Walker CJ, Walker MC, Oakes CC, Orwick S, Carroll AJ, Blum WG, Powell BL, Kolitz JE, Moore JO, Mayer RJ, Larson RA, Stone RM, Byrd JC, Metzeler KH, Herold T, Eisfeld AK

doi: 10.1038/s41375-025-02644-0

Sarcoma

Trabectedin in the treatment of soft tissue sarcoma: Real-world data on effectiveness, safety, and financial implications from a European comprehensive cancer center

Int J Cancer

Giraud JS, Watson S, Acramel A, Laurence V, Tzanis D, Bonvalot S, El Zein S, Nicolas N, Cros C, Desmaris R, Bonnet C

doi: 10.1002/ijc.70403

Lung, Respiratory and Thoracic Cancer

Treatment outcome of NSCLC patients with BRAF(non-V600E) mutations: a retrospective, multicentre analysis within the national Network Genomic Medicine (nNGM) Lung Cancer in Germany

ESMO Open

Kropf-Sanchen C, Rasokat A, Christopoulos P, Wenzel C, Wehler T, Rost M, Kulhavy J, Reinmuth N, Schulz C, Scheffler M, Wolf J, Büttner R, Merkelbach-Bruse S, Thomas M, Stenzinger A, Schütz M, Bräuninger A, Demes M, Hummel HD, Pfarr N, Gaisa NT, Rawluk J, Berezucki E, Lutz KT, Galda S, Jacobi H, Collienne M, Janning M, Brummer T, Loges S, nNGM Lung Cancer

doi: 10.1016/j.esmoop.2025.105124

Breast Cancer

Recent treatment and survival trends in older versus younger women with HR-positive HER2-negative metastatic breast cancer in the real-life multicenter French ESME cohort

Eur J Cancer

Bouteiller F, Gourgou S, Bringuier M, Galvin A, Mailliez A, Bertrand N, Hung M, Frenel JS, Massard V, Bachelot T, Pflumio C, Gonçalves A, Levy C, Bosquet L, Jacot W, Delaloge S, Grinda T, Bellera C

doi: 10.1016/j.ejca.2025.116166

Leukemia

ATRA treatment in the emergency department is associated with reduced early mortality in acute promyelocytic leukemia-a real-world multicenter retrospective cohort analysis

Leuk Lymphoma

O'Brien J, Tomlinson B, Patel MJ, Van Besien K, Brown J, Lazarus H, O'Brien T

doi: 10.1080/10428194.2026.2623196

Related content

Maintenance Chemotherapy in Patients With High-Risk Rhabdomyosarcoma: Long-Term Survival Analysis of the European Paediatric Soft Tissue Sarcoma Study Group RMS 2005 Trial

Outcome of 1773 superficial non-dermatofibrosarcoma sarcomas A French Sarcoma Group study (FSG) from the NETSARC database

First-line treatment efficacy of anti-EGFR versus anti-VEGF antibodies in BRAF(V600E)-mutated metastatic colorectal cancer according to primary tumor sidedness: A pooled analysis of seven clinical trials performed in the first-line treatment of mCRC (German AIO Study Group)

Efficacy and safety of treatments for metastatic castration-sensitive prostate cancer: A comprehensive network meta-analysis including final ARANOTE data

Multi-dimensional analysis of adult acute myeloid leukemia cross-continents reveals age-associated trends in mutational landscape and treatment outcomes (Acute Myeloid Leukemia Cooperative Group & Alliance for Clinical Trials in Oncology)

Trabectedin in the treatment of soft tissue sarcoma: Real-world data on effectiveness, safety, and financial implications from a European comprehensive cancer center

Treatment outcome of NSCLC patients with BRAF(non-V600E) mutations: a retrospective, multicentre analysis within the national Network Genomic Medicine (nNGM) Lung Cancer in Germany

Recent treatment and survival trends in older versus younger women with HR-positive HER2-negative metastatic breast cancer in the real-life multicenter French ESME cohort

ATRA treatment in the emergency department is associated with reduced early mortality in acute promyelocytic leukemia-a real-world multicenter retrospective cohort analysis